These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 9244390

  • 1. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
    Walter M, Plotnick M, Schechter NM.
    Arch Biochem Biophys; 1996 Mar 01; 327(1):81-8. PubMed ID: 8615699
    [Abstract] [Full Text] [Related]

  • 3. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
    Schechter NM, Brass LF, Lavker RM, Jensen PJ.
    J Cell Physiol; 1998 Aug 01; 176(2):365-73. PubMed ID: 9648924
    [Abstract] [Full Text] [Related]

  • 4. Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors.
    He SH, Chen P, Chen HQ.
    Acta Pharmacol Sin; 2003 Sep 01; 24(9):923-9. PubMed ID: 12956943
    [Abstract] [Full Text] [Related]

  • 5. Kinetic studies on the inhibitions of mast cell chymase by natural serine protease inhibitors: indications for potential biological functions of these inhibitors.
    Fukusen N, Kato Y, Kido H, Katunuma N.
    Biochem Med Metab Biol; 1987 Oct 01; 38(2):165-9. PubMed ID: 3479119
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor.
    Scarpi D, McBride JD, Leatherbarrow RJ.
    Bioorg Med Chem; 2004 Dec 01; 12(23):6045-52. PubMed ID: 15519150
    [Abstract] [Full Text] [Related]

  • 7. [The classical Bowman-Birk soy inhibitor is an effective inhibitor of human granulocyte alpha-chymotrypsin and cathepsin G].
    Gladysheva IP, Larionova NI, Gladyshev DP, Tikhonova TV, Kazanskaia NF.
    Biokhimiia; 1994 Apr 01; 59(4):513-8. PubMed ID: 8018773
    [Abstract] [Full Text] [Related]

  • 8. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase.
    Goldstein SM, Leong J, Schwartz LB, Cooke D.
    J Immunol; 1992 Apr 15; 148(8):2475-82. PubMed ID: 1560203
    [Abstract] [Full Text] [Related]

  • 9. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
    Schechter NM, Irani AM, Sprows JL, Abernethy J, Wintroub B, Schwartz LB.
    J Immunol; 1990 Oct 15; 145(8):2652-61. PubMed ID: 2212656
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interaction of human leukocyte elastase with plasma fibronectin and its inhibition by soybean Bowman-Birk protease inhibitor.
    Larionova NI, Balabushevitch NG, Zhatikov PA.
    Biochemistry (Mosc); 1998 Sep 15; 63(9):1078-82. PubMed ID: 9795279
    [Abstract] [Full Text] [Related]

  • 12. Interaction between duodenase, a proteinase with dual specificity, and soybean inhibitors of Bowman-Birk and Kunitz type.
    Gladysheva IP, Zamolodchikova TS, Sokolova EA, Larionova NI.
    Biochemistry (Mosc); 1999 Nov 15; 64(11):1244-9. PubMed ID: 10611528
    [Abstract] [Full Text] [Related]

  • 13. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW, Huang SC, Lin-Shiau SY, Lin JK.
    Carcinogenesis; 2005 Jul 15; 26(7):1296-306. PubMed ID: 15746161
    [Abstract] [Full Text] [Related]

  • 14. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y, Kido H, Kawaji K, Kamoshita K, Katunuma N, Ogura T.
    Arch Biochem Biophys; 1994 Jul 15; 312(1):67-74. PubMed ID: 8031148
    [Abstract] [Full Text] [Related]

  • 15. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
    Kaminska R, Harvima IT, Naukkarinen A, Nilsson G, Horsmanheimo M.
    J Pathol; 1996 Dec 15; 180(4):434-40. PubMed ID: 9014866
    [Abstract] [Full Text] [Related]

  • 16. Biological functions of serine proteases in mast cells in allergic inflammation.
    Katunuma N, Kido H.
    J Cell Biochem; 1988 Dec 15; 38(4):291-301. PubMed ID: 2467915
    [Abstract] [Full Text] [Related]

  • 17. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
    He S, Gaça MD, McEuen AR, Walls AF.
    J Pharmacol Exp Ther; 1999 Nov 15; 291(2):517-23. PubMed ID: 10525066
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor.
    Billings PC, Habres JM, Liao DC, Tuttle SW.
    Cancer Res; 1991 Oct 15; 51(20):5539-43. PubMed ID: 1913672
    [Abstract] [Full Text] [Related]

  • 20. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport.
    Dittmann K, Mayer C, Kehlbach R, Rodemann HP.
    Radiother Oncol; 2008 Mar 15; 86(3):375-82. PubMed ID: 18237807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.